Numaferm Revenue and Competitors
Estimated Revenue & Valuation
- Numaferm's estimated annual revenue is currently $2M per year.
- Numaferm's estimated revenue per employee is $98,000
Employee Data
- Numaferm has 20 Employees.
- Numaferm grew their employee count by -17% last year.
Numaferm's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Scientist Downstream Processing & Analytics | Reveal Email/Phone |
5 | Associate Scientist | Reveal Email/Phone |
6 | Senior Scientist Downstream Processing & Analytics | Reveal Email/Phone |
7 | Senior Scientist | Reveal Email/Phone |
8 | BTA Downstream Processing & Analytics | Reveal Email/Phone |
Numaferm Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 14 | -26% | N/A | N/A |
#2 | $22.2M | 144 | 18% | N/A | N/A |
#3 | $2.5M | 26 | 37% | N/A | N/A |
#4 | $69.1M | 395 | 12% | N/A | N/A |
#5 | $5.2M | 46 | 0% | N/A | N/A |
#6 | $15.1M | 108 | 8% | N/A | N/A |
#7 | $21.2M | 141 | -20% | $70M | N/A |
#8 | $2.7M | 28 | 8% | N/A | N/A |
#9 | $1M | 12 | 9% | N/A | N/A |
#10 | $13.7M | 98 | 46% | N/A | N/A |
What Is Numaferm?
We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
keywords:N/AN/A
Total Funding
20
Number of Employees
$2M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Numaferm News
2022-04-06 - The peptide therapeutics contract API manufacturing market is ...
... Philipp Burling (Chief Financial Officer, NUMAFERM). The research includes detailed profiles of key service providers (listed below)...
2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...
... NSJ Prayog Life Sciences; NUMAFERM; ONL Therapeutics; OPKO Health; Oramed Pharmaceuticals; ORPEGEN Peptide Chemicals; Oryn Therapeutics...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 21 | 17% | N/A |
#2 | $2.1M | 21 | 0% | N/A |
#3 | $2M | 22 | 0% | N/A |
#4 | $2.5M | 28 | -30% | N/A |
#5 | $4.8M | 31 | 35% | N/A |